Yale University

Cost-effectiveness of HIV treatment as prevention in serodiscordant couples.

TitleCost-effectiveness of HIV treatment as prevention in serodiscordant couples.
Publication TypeJournal Article
Year of Publication2013
AuthorsWalensky, Rochelle P., Eric L. Ross, Nagalingeswaran Kumarasamy, Robin Wood, Farzad Noubary, David A. Paltiel, Yoriko M. Nakamura, Sheela V. Godbole, Ravindre Panchia, Ian Sanne, Milton C. Weinstein, Elena Losina, Kenneth H. Mayer, Ying Q. Chen, Lei Wang, Marybeth McCauley, Theresa Gamble, George R. Seage, Myron S. Cohen, and Kenneth A. Freedberg
JournalThe New England journal of medicine
Date Published2013 Oct 31
KeywordsAdult, Anti-Retroviral Agents, Cost-Benefit Analysis, Disease Transmission, Infectious, Drug Administration Schedule, Female, Gross Domestic Product, Health Care Costs, HIV Infections, Humans, India, Male, South Africa
AbstractThe cost-effectiveness of early antiretroviral therapy (ART) in persons infected with human immunodeficiency virus (HIV) in serodiscordant couples is not known. Using a computer simulation of the progression of HIV infection and data from the HIV Prevention Trials Network 052 study, we projected the cost-effectiveness of early ART for such persons.
Alternate JournalN. Engl. J. Med.

External Links